Compare CODA & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CODA | SEER |
|---|---|---|
| Founded | 1994 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 155.4M | 111.4M |
| IPO Year | 2007 | 2020 |
| Metric | CODA | SEER |
|---|---|---|
| Price | $12.54 | $1.72 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 341.2K | ★ 363.6K |
| Earning Date | 03-17-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 15.62 | 9.40 |
| EPS | ★ 0.08 | N/A |
| Revenue | ★ $20,316,161.00 | $16,578,000.00 |
| Revenue This Year | $16.42 | $2.14 |
| Revenue Next Year | $14.43 | $25.90 |
| P/E Ratio | $161.88 | ★ N/A |
| Revenue Growth | 4.98 | ★ 16.99 |
| 52 Week Low | $5.76 | $1.62 |
| 52 Week High | $18.00 | $2.41 |
| Indicator | CODA | SEER |
|---|---|---|
| Relative Strength Index (RSI) | 44.56 | 39.78 |
| Support Level | $7.25 | $1.69 |
| Resistance Level | $14.89 | $1.97 |
| Average True Range (ATR) | 1.21 | 0.07 |
| MACD | -0.36 | -0.01 |
| Stochastic Oscillator | 4.40 | 23.91 |
Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. The company operates in three distinct business segments: the Marine Technology business, Acoustic Sensors and Material Business and the Defense Engineering Services Business. Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Products segment.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.